Structures by: Virieux D.
Total: 36
C30H22Br2O6P2
C30H22Br2O6P2
Organic letters (2017)
a=27.0189(6)Å b=14.0226(4)Å c=7.2637(2)Å
α=90° β=90° γ=90°
C12H18NO2P
C12H18NO2P
Organic & biomolecular chemistry (2010) 8, 6 1438-1444
a=13.4636(10)Å b=8.4643(4)Å c=12.3030(9)Å
α=90° β=113.455(9)° γ=90°
C12H17Cl1N1O2P1
C12H17Cl1N1O2P1
Organic & biomolecular chemistry (2010) 8, 6 1438-1444
a=8.11924(19)Å b=10.0431(2)Å c=16.0275(4)Å
α=90° β=96.047(2)° γ=90°
C12H17ClNO2P
C12H17ClNO2P
Organic & biomolecular chemistry (2010) 8, 6 1438-1444
a=13.4738(6)Å b=8.3372(4)Å c=12.4129(6)Å
α=90° β=92.615(4)° γ=90°
C8H13N2O5P
C8H13N2O5P
RSC Adv. (2014) 4, 45 23770
a=4.47500(10)Å b=13.8149(2)Å c=8.7194(2)Å
α=90° β=94.575(2)° γ=90°
C9H15N2O6P,H2O
C9H15N2O6P,H2O
RSC Adv. (2014) 4, 45 23770
a=6.6374(3)Å b=24.5838(15)Å c=7.9643(4)Å
α=90° β=101.181(5)° γ=90°
C10H13N2O5P
C10H13N2O5P
RSC Adv. (2014) 4, 45 23770
a=7.8726(2)Å b=10.7546(3)Å c=14.0957(5)Å
α=90° β=97.274(3)° γ=90°
C21H27F4N2O3P
C21H27F4N2O3P
RSC Advances (2019) 9, 42 24117
a=8.8604(4)Å b=9.8978(8)Å c=13.1171(7)Å
α=91.889(5)° β=91.350(4)° γ=109.119(6)°
C19H23F4N2O3P
C19H23F4N2O3P
RSC Advances (2019) 9, 42 24117
a=11.7691(9)Å b=12.2935(5)Å c=16.8735(9)Å
α=101.120(4)° β=99.040(5)° γ=118.147(6)°
C66H35Cl6N3O6P3
C66H35Cl6N3O6P3
CrystEngComm (2011) 13, 20 6050
a=8.769(2)Å b=15.024(2)Å c=21.216(2)Å
α=94.818(3)° β=99.983(5)° γ=98.226(6)°
C54H30N3O6P3
C54H30N3O6P3
CrystEngComm (2011) 13, 20 6050
a=14.909(2)Å b=31.013(4)Å c=9.0740(10)Å
α=90.00° β=102.120(7)° γ=90.00°
C42H34Cl2N6P2Pt
C42H34Cl2N6P2Pt
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12539-12545
a=25.778(5)Å b=17.954(5)Å c=19.364(5)Å
α=90.000(5)° β=104.467(5)° γ=90.000(5)°
C36H38N6O2P2
C36H38N6O2P2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12539-12545
a=23.4908(5)Å b=11.0856(2)Å c=25.9333(5)Å
α=90° β=90.8818(18)° γ=90°
2(C42H34N6O2P2),C2H3N
2(C42H34N6O2P2),C2H3N
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12539-12545
a=12.8008(2)Å b=16.6628(3)Å c=17.8668(3)Å
α=90° β=99.6830(17)° γ=90°
C42H34Cl2N6P2Pd,4(C2H3N)
C42H34Cl2N6P2Pd,4(C2H3N)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12539-12545
a=22.5985(2)Å b=10.81823(12)Å c=20.4451(3)Å
α=90° β=90.0860(10)° γ=90°
C42H34Cl2N6P2Pd,CHCl3
C42H34Cl2N6P2Pd,CHCl3
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12539-12545
a=20.0222(3)Å b=18.8861(4)Å c=22.6056(4)Å
α=90° β=94.2374(16)° γ=90°
C50H46ClIrN6P2,(CHCl3)3
C50H46ClIrN6P2,(CHCl3)3
Dalton transactions (Cambridge, England : 2003) (2015) 44, 28 12539-12545
a=14.3765(3)Å b=14.3894(3)Å c=16.3672(3)Å
α=113.044(2)° β=95.930(2)° γ=111.798(2)°
(2R,3S,5S)-3,5-diphenyl-2-(4-methoxyphenyl)- [1,4,2]-oxazaphosphorinane2-oxide
C22H22N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=10.0104(3)Å b=8.10560(10)Å c=12.5372(3)Å
α=90° β=109.717(5)° γ=90°
(2S,3S,5S)-2,3,5-triphenyl-[1,4,2]-oxazaphosphorinane 2-oxide
C21H20N1O2P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=5.6212(6)Å b=25.714(2)Å c=13.561(2)Å
α=90° β=90° γ=90°
(2R,3S,5S)-3,5-diphenyl-[1,4,2]-oxazaphosphorinane 2-oxide.
C15H16N1O2P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=5.3914(2)Å b=11.7559(4)Å c=21.6032(8)Å
α=90° β=90° γ=90°
(2S,4S,5R)and(2R,4R,5S)-3-tert-butyl-2-ethyl-4,5- diphenyl-[1,3,2]-oxazaphospholidine2-oxide
C20H26NO2P
Acta Crystallographica Section B (2008) 64, 2 196-205
a=6.7231(5)Å b=11.9766(6)Å c=23.6865(16)Å
α=97.644(3)° β=93.038(2)° γ=98.742(2)°
(2S,4S,5R)-3-tert-butyl-2-[(1S)-1-?uoro-1-methyl- 2-oxo-propyl]-4,5-diphenyl-[1,3,2]-oxazaphospholidine2- oxide
C22H27F1N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=6.411(2)Å b=16.206(4)Å c=21.242(5)Å
α=90° β=99.51(2)° γ=90°
(2R,4R,5S)-3-tert-butyl-2-[(1R)-1-methyl-2-oxo- propyl]-4,5-diphenyl-[1,3,2]-oxazaphospholidine2-oxide
C22H28N1O3P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=12.109(3)Å b=14.047(3)Å c=13.206(6)Å
α=90° β=111.48(3)° γ=90°
(2R,4S,5R)-3-tert-butyl-2-benzyl-4,5-diphenyl- [1,3,2]-oxazaphospholidine2-oxide
C25H28N1O2P1
Acta Crystallographica Section B (2008) 64, 2 196-205
a=10.284(2)Å b=21.262(4)Å c=12.768(2)Å
α=90° β=119.04(2)° γ=90°
3-Chloromethyl-5-methoxy-4-methoxycarbonyl-3-oxo-2,3-dihydro-[1,3]oxaphosphole monohydrate
C7H10ClO5P,H2O
Acta Crystallographica Section E (2004) 60, 1 o99-o101
a=7.6307(7)Å b=8.5404(8)Å c=9.1204(10)Å
α=71.019(9)° β=81.102(8)° γ=72.999(8)°
C6H6NO5P
C6H6NO5P
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=7.462(2)Å b=7.805(2)Å c=8.031(2)Å
α=68.53(3)° β=63.42(3)° γ=88.31(3)°
C6H6NO5P
C6H6NO5P
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=5.565(2)Å b=12.901(4)Å c=10.161(3)Å
α=90° β=98.32(3)° γ=90°
C6H6NO5P
C6H6NO5P
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=8.864(3)Å b=9.920(3)Å c=9.500(3)Å
α=90° β=115.80(3)° γ=90°
C6H6NO5P,H2O
C6H6NO5P,H2O
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=9.349(3)Å b=9.590(3)Å c=10.611(4)Å
α=69.88(4)° β=72.00(4)° γ=74.94(4)°
C6H6NO5P,H2O
C6H6NO5P,H2O
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=7.497(2)Å b=9.928(3)Å c=23.123(6)Å
α=90° β=90° γ=90°
C5H7NO6P2
C5H7NO6P2
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=4.948(2)Å b=12.937(3)Å c=13.024(3)Å
α=90° β=90° γ=90°
C6H12NO5P
C6H12NO5P
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=5.930(2)Å b=13.177(3)Å c=11.050(3)Å
α=90° β=95.51(3)° γ=90°
C6H12NO5P,H2O
C6H12NO5P,H2O
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=7.586(2)Å b=6.943(2)Å c=18.472(4)Å
α=90° β=99.37(3)° γ=90°
C6H9NO6P2
C6H9NO6P2
The Journal of organic chemistry (2016) 81, 12 4947-4954
a=13.410(4)Å b=8.969(3)Å c=17.268(5)Å
α=90° β=110.48(3)° γ=90°
C28H30NO5PS
C28H30NO5PS
Journal of Organic Chemistry (2005) 70, 7035-7041
a=13.103Å b=10.466Å c=20.244Å
α=90.00° β=102.35° γ=90.00°
(2R,4S,5R)-3-tert-butyl-2-ethyl-4,5-diphenyl- [1,3,2]-oxazaphospholidine2-oxide
C20H26NO2P
Acta Crystallographica Section B (2008) 64, 2 196-205
a=10.5381(8)Å b=15.7519(14)Å c=22.626(2)Å
α=90° β=90° γ=90°